Detalhe da pesquisa
1.
Sex and ethnic disparities in hepatitis B evaluation and treatment across the world.
J Hepatol
; 81(1): 33-41, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38906621
2.
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study.
Clin Gastroenterol Hepatol
; 22(3): 572-580.e5, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734582
3.
Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.
Hepatology
; 78(5): 1558-1568, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37184202
4.
Endobronchial spread of adenocarcinoma is a distinct pattern of invasion and associated with inferior clinical outcomes in lung adenocarcinoma.
Histopathology
; 84(4): 646-660, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38148681
5.
Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction-associated steatotic liver disease.
Liver Int
; 44(7): 1700-1714, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558221
6.
A new criterion including the aspartate aminotransferase-to-platelet ratio index and liver and spleen stiffness to rule out varices needing treatment in children with biliary atresia: Modification of the Baveno VII criteria.
Hepatol Res
; 54(4): 347-357, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843392
7.
RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury.
Hepatol Res
; 54(6): 503-512, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642343
8.
Diagnostic guide for immune checkpoint inhibitor-induced liver injury.
Hepatol Res
; 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38884591
9.
Outcomes of immune checkpoint inhibitor-induced liver toxicity managed by hepatologists in a multidisciplinary toxicity team.
Hepatol Res
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38571477
10.
Safety and effectiveness of SARS-CoV-2 vaccines for patients with intractable hepatobiliary diseases: A multicenter, questionnaire-based, cross-sectional study.
Hepatol Res
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300669
11.
Predictability of noninvasive liver fibrosis score for cardiac events in patients with nonalcoholic fatty liver disease.
Nutr Metab Cardiovasc Dis
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38664121
12.
Descriptive analysis of incidence and risk factors for short intramedullary nail breakage in femoral intertrochanteric fractures: a multicenter (TRON group) retrospective study.
Eur J Orthop Surg Traumatol
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713443
13.
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons.
J Hepatol
; 79(2): 287-295, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37040843
14.
Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients.
Clin Gastroenterol Hepatol
; 21(4): 1013-1022.e6, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654298
15.
Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome.
Rheumatology (Oxford)
; 2023 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606963
16.
Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis.
Invest New Drugs
; 41(3): 512-521, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171720
17.
Mitochondrial phosphatidylethanolamine synthesis affects mitochondrial energy metabolism and quiescence entry through attenuation of Snf1/AMPK signaling in yeast.
FASEB J
; 36(7): e22355, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639425
18.
Differences in the Intestinal Microbiome Associated with Diarrhea during Lenvatinib Treatment for Hepatocellular Carcinoma.
Dig Dis
; 41(1): 138-147, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344958
19.
Clustering using unsupervised machine learning to stratify the risk of immune-related liver injury.
J Gastroenterol Hepatol
; 38(2): 251-258, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302734
20.
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning.
J Gastroenterol Hepatol
; 38(10): 1832-1839, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37596843